Have a personal or library account? Click to login
Quantitative assessment of bone marrow infiltration and characterization of tumor burden using dual-layer spectral CT in patients with multiple myeloma Cover

Quantitative assessment of bone marrow infiltration and characterization of tumor burden using dual-layer spectral CT in patients with multiple myeloma

Open Access
|Jan 2024

References

  1. Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol 2016; 43: 676–81. doi: <a href="https://doi.org/10.1053/j.seminoncol.2016.11.004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1053/j.seminoncol.2016.11.004</a>
  2. Panaroni C, Yee AJ, Raje NS. Myeloma and bone disease. Curr Osteoporos Rep 2017; 15: 483–98. doi: <a href="https://doi.org/10.1007/s11914-017-0397-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11914-017-0397-5</a>
  3. O’Donnell EK, Raje NS. Myeloma bone disease: pathogenesis and treatment. Clin Adv Hematol Oncol 2017; 15: 285–95. PMID: 28591104
  4. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014; 15: e538–48. doi: <a href="https://doi.org/10.1016/S1470-2045(14)70442-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1470-2045(14)70442-5</a>
  5. Duvauferrier R, Valence M, Patrat-Delon S, Brillet E, Niederberger E, Marchand A, et al. Current role of CT and whole body MRI in multiple myeloma. Diagn Interv Imaging 2013; 94: 169–83. doi: <a href="https://doi.org/10.1016/j.diii.2012.12.001" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.diii.2012.12.001</a>
  6. Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, et al. International Myeloma Working Group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia 2009; 23: 1545–56. doi: <a href="https://doi.org/10.1038/leu.2009.89" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/leu.2009.89</a>
  7. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842–54. doi: <a href="https://doi.org/10.1002/1097-0142(197509)36:3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/1097-0142(197509)36:3</a><842::aid-cncr2820360303>3.0.co;2-u
  8. Portet M, Owens E, Howlett D. The use of whole-body MRI in multiple myeloma. Clin Med 2019; 19: 355–6. doi: <a href="https://doi.org/10.7861/clinmedicine.19-4-355" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.7861/clinmedicine.19-4-355</a>
  9. Kosmala A, Weng AM, Heidemeier A, Krauss B, Knop S, Bley TA, et al. Multiple myeloma and dual-energy CT: diagnostic accuracy of virtual non-calcium technique for detection of bone marrow infiltration of the spine and pelvis. Radiology 2018; 286: 205–13. doi: <a href="https://doi.org/10.1148/radiol.2017170281" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1148/radiol.2017170281</a>
  10. Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, et al. International Myeloma Working Group consensus recommendations on imaging in monoclonal plasma cell disorders. Lancet Oncol 2019; 20: e302–e312. doi: <a href="https://doi.org/10.1016/S1470-2045(19)30309-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1470-2045(19)30309-2</a>
  11. Shah LM, Hanrahan CJ. MRI of spinal bone marrow: part I, techniques and normal age-related appearances. AJR Am J Roentgenol 2011; 197: 1298–308. doi: <a href="https://doi.org/10.2214/AJR.11.7005" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2214/AJR.11.7005</a>
  12. Padhani AR, Koh DM, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011; 261: 700–18. doi: <a href="https://doi.org/10.1148/radiol.11110474" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1148/radiol.11110474</a>
  13. Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of (18)F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol 2017; 18: e206–e217. doi: <a href="https://doi.org/10.1016/S1470-2045(17)30189-4" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1470-2045(17)30189-4</a>
  14. Fervers P, Fervers F, Kottlors J, Lohneis P, Pollman-Schweckhorst P, Zaytoun H, et al. Feasibility of artificial intelligence-supported assessment of bone marrow infiltration using dual-energy computed tomography in patients with evidence of monoclonal protein - a retrospective observational study. Eur Radiol 2022; 32: 2901–11. doi: <a href="https://doi.org/10.1007/s00330-021-08419-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00330-021-08419-2</a>
  15. Fervers P, Glauner A, Gertz R, Täger P, Kottlors J, Maintz D, et al. Virtual calcium-suppression in dual energy computed tomography predicts metabolic activity of focal MM lesions as determined by fluorodeoxyglucose positron-emission-tomography. Eur J Radiol 2021; 135: 109502. doi: <a href="https://doi.org/10.1016/j.ejrad.2020.109502" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejrad.2020.109502</a>
  16. Brandelik SC, Skornitzke S, Mokry T, Sauer S, Stiller W, Nattenmüller J, et al. Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT. Eur Radiol 2021; 31: 7664–73. doi: <a href="https://doi.org/10.1007/s00330-021-07821-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00330-021-07821-0</a>
  17. Moulopoulos LA, Koutoulidis V, Hillengass J, Zamagni E, Aquerreta JD, Roche CL, et al. Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group. Blood Cancer J 2018; 8: 95. doi: <a href="https://doi.org/10.1038/s41408-018-0124-1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/s41408-018-0124-1</a>
  18. Reinert CP, Krieg E, Esser M, Nikolaou K, Bösmüller H, Horger M. Role of computed tomography texture analysis using dual-energy-based bone marrow imaging for multiple myeloma characterization: comparison with histology and established serologic parameters. Eur Radiol 2021; 31: 2357–67. doi: <a href="https://doi.org/10.1007/s00330-020-07320-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00330-020-07320-8</a>
  19. Hu C, Zhang Y, Xiong X, Meng Q, Yao F, Ye A, et al. Quantitative evaluation of bone marrow infiltration using dual-energy spectral computed tomography in patients with multiple myeloma. J Xray Sci Technol 2021; 29: 463–75. doi: <a href="https://doi.org/10.3233/XST-200811" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3233/XST-200811</a>
  20. Mosebach J, Thierjung H, Schlemmer HP, Delorme S. Multiple myeloma guidelines and their recent updates: implications for imaging. Rofo 2019; 191: 998–1009. doi: <a href="https://doi.org/10.1055/a-0897-3966" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1055/a-0897-3966</a>
  21. Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA 2022; 327: 464–77. doi: <a href="https://doi.org/10.1001/jama.2022.0003" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1001/jama.2022.0003</a>
  22. Thomas C, Schabel C, Krauss B, Weisel K, Bongers M, Claussen CD, et al. Dual-energy CT: virtual calcium subtraction for assessment of bone marrow involvement of the spine in multiple myeloma. AJR Am J Roentgenol 2015; 204: W324–31. doi: <a href="https://doi.org/10.2214/AJR.14.12613" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2214/AJR.14.12613</a>
  23. Ekert K, Hinterleitner C, Baumgartner K, Fritz J, Horger M. Extended texture analysis of non-enhanced whole-body MRI image data for response assessment in multiple myeloma patients undergoing systemic therapy. Cancers 2020; 12: 761. doi: <a href="https://doi.org/10.3390/cancers12030761" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/cancers12030761</a>
  24. Yu Z, Leng S, Jorgensen SM, Li Z, Gutjahr R, Chen B, et al. Evaluation of conventional imaging performance in a research whole-body CT system with a photon-counting detector array. Phys Med Biol 2016; 61: 1572–95. doi: <a href="https://doi.org/10.1088/0031-9155/61/4/1572" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1088/0031-9155/61/4/1572</a>
  25. Koutoulidis V, Terpos E, Papanikolaou N, Fontara S, Seimenis I, Gavriatopoulou M, et al. Comparison of MRI features of fat fraction and ADC for early treatment response assessment in participants with multiple myeloma. Radiology 2022; 304: 137–44. doi: <a href="https://doi.org/10.1148/radiol.211388" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1148/radiol.211388</a>
  26. Sidiqi MH, Aljama M, Kumar SK, Jevremovic D, Buadi FK, Warsame R, et al. The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? Blood Cancer J 2020; 10: 52. doi: <a href="https://doi.org/10.1038/s41408-020-0319-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/s41408-020-0319-0</a>
  27. Dupuis MM, Tuchman SA. Non-secretory multiple myeloma: from biology to clinical management. Onco Targets Ther 2016; 9: 7583–90. doi: <a href="https://doi.org/10.2147/OTT.S122241" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2147/OTT.S122241</a>
  28. Wale A, Pawlyn C, Kaiser M, Messiou C. Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma. Haematologica 2016; 101: e142–4. doi: <a href="https://doi.org/10.3324/haematol.2015.139816" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3324/haematol.2015.139816</a>
  29. Hamdaoui H, Benlarroubia O, Ait Boujmia OK, Mossafa H, Ouldim K, Belkhayat A, et al. Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients. Mol Genet Genomic Med 2020; 8: e1363. doi: <a href="https://doi.org/10.1002/mgg3.1363" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/mgg3.1363</a>
  30. Saxe D, Seo EJ, Bergeron MB, Han JY. Recent advances in cytogenetic characterization of multiple myeloma. Int J Lab Hematol 2019; 41: 5–14. doi: <a href="https://doi.org/10.1111/ijlh.12882" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/ijlh.12882</a>
  31. Zhao XQ, Zhao SY, Chen WX, Liu XW, Yan HX, Lou YJ. Correlation between clinical factors and prognosis in newly diagnosed multiple myeloma. J Coll Physicians Surg Pak 2020; 30: 601–5. doi: <a href="https://doi.org/10.29271/jcpsp.2020.06.601" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.29271/jcpsp.2020.06.601</a>
  32. Usmani SZ, Crowley J, Hoering A, Mitchell A, Waheed S, Nair B, et al. Improvement in long-term outcomes with successive total therapy trials for multiple myeloma: are patients now being cured? Leukemia 2013; 27: 226–32. doi: <a href="https://doi.org/10.1038/leu.2012.160" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/leu.2012.160</a>
  33. Ross FM, Avet-Loiseau H, Ameye G, Gutiérrez NC, Liebisch P, O’Connor S, et al. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders. Haematologica 2012; 97: 1272–7. doi: <a href="https://doi.org/10.3324/haematol.2011.056176" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3324/haematol.2011.056176</a>
DOI: https://doi.org/10.2478/raon-2024-0003 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 43 - 50
Submitted on: Aug 18, 2023
Accepted on: Oct 31, 2023
Published on: Jan 6, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2024 Xing Xiong, Rong Hong, Xu Fan, Zhengmei Hao, Xiaohui Zhang, Yu Zhang, Chunhong Hu, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.